[HTML][HTML] Recent advances in electrochemical biosensors–A brief review
MS Sumitha, TS Xavier - Hybrid Advances, 2023 - Elsevier
A sensitive biological system and a detector system with appropriate transducers for
obtaining the output signals make up a biosensor. These devices have a wide range of …
obtaining the output signals make up a biosensor. These devices have a wide range of …
A comprehensive SARS-CoV-2 and COVID-19 review, Part 2: host extracellular to systemic effects of SARS-CoV-2 infection
SA Narayanan, DA Jamison Jr, JW Guarnieri… - European Journal of …, 2024 - nature.com
COVID-19, the disease caused by SARS-CoV-2, has caused significant morbidity and
mortality worldwide. The betacoronavirus continues to evolve with global health implications …
mortality worldwide. The betacoronavirus continues to evolve with global health implications …
Neuroinflammation and Its Impact on the Pathogenesis of COVID-19
MM Almutairi, F Sivandzade, TH Albekairi… - Frontiers in …, 2021 - frontiersin.org
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). The clinical manifestations of COVID-19 …
respiratory syndrome coronavirus 2 (SARS-CoV-2). The clinical manifestations of COVID-19 …
Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a …
JR Baker, M Mahdi, DV Nicolau… - The Lancet …, 2022 - thelancet.com
Background Community-based clinical trials of the inhaled corticosteroid budesonide in
early COVID-19 have shown improved patient outcomes. We aimed to understand the …
early COVID-19 have shown improved patient outcomes. We aimed to understand the …
[HTML][HTML] Circulating microRNAs as emerging regulators of COVID-19
Y Liang, D Fang, X Gao, X Deng, N Chen, J Wu… - Theranostics, 2023 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19), an infectious disease caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global pandemic that …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global pandemic that …
The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review
S Paul, LAB Vázquez, PR Reyes-Pérez… - Virus Research, 2022 - Elsevier
Nowadays, one of the major global health concerns is coronavirus disease 2019 (COVID-
19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV …
19), which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV …
Circulating microRNA signatures associated with disease severity and outcome in COVID-19 patients
A Giannella, S Riccetti, A Sinigaglia, C Piubelli… - Frontiers in …, 2022 - frontiersin.org
Background SARS-CoV-2 induces a spectrum of clinical conditions ranging from
asymptomatic infection to life threatening severe disease. Host microRNAs have been …
asymptomatic infection to life threatening severe disease. Host microRNAs have been …
Exosomal miR-145 and miR-885 regulate thrombosis in COVID-19
We hypothesized that exosomal microRNAs could be implied in the pathogenesis of
thromboembolic complications in coronavirus disease 2019 (COVID-19). We isolated …
thromboembolic complications in coronavirus disease 2019 (COVID-19). We isolated …
Cellular miR-150-5p may have a crucial role to play in the biology of SARS-CoV-2 infection by regulating nsp10 gene
SM Akula, P Bolin, PP Cook - RNA biology, 2022 - Taylor & Francis
The role for circulating miRNAs as biomarkers of the COVID-19 disease remains uncertain.
We analysed the circulating miRNA profile in twelve COVID-19 patients with moderate …
We analysed the circulating miRNA profile in twelve COVID-19 patients with moderate …
Non-coding RNAs expression in SARS-CoV-2 infection: pathogenesis, clinical significance, and therapeutic targets
X Liu, W Xiong, M Ye, T Lu, K Yuan, S Chang… - … and Targeted Therapy, 2023 - nature.com
Abstract The coronavirus disease 2019 (COVID-19) pandemic has been looming globally for
three years, yet the diagnostic and treatment methods for COVID-19 are still undergoing …
three years, yet the diagnostic and treatment methods for COVID-19 are still undergoing …